TL
Ted W Love
President and CEODirector

Ted W Love insider trades: Global Blood Therapeutics (GBT) stock buys and sales

President and CEO, Global Blood Therapeutics Last trade Apr 28, 2020 118 Form 4 filings
$0
Sold, last 12 months
0 sales
$0
Bought, last 12 months
0 buys
10
Open-market trades
since 2008
18
Companies
last trade 2020

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Ted reports to the SEC

and 12 more companies

Open-market buys and sales

10 trades reported on SEC Form 4, newest first

DateStockTypeValue
Apr 28, 2020GBT↓ Sell$3.4M
Feb 18, 2020GBT↓ Sell$283K
Jan 22, 2020GBT↓ Sell$6.6M
Dec 6, 2019GBT↓ Sell$6.1M
Feb 2, 2017CASC↑ Buy$98K
Aug 17, 2015GBT↑ Buy$100K
Aug 17, 2015GBT↑ Buy$50K
Dec 18, 2012SNTS↑ Buy$2.0M
Jul 25, 2012ONXX↓ Sell$388K
Mar 24, 2008NUVO↑ Buy$19K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

About Ted W Love's insider trades

Ted W Love is President and CEO at Global Blood Therapeutics (GBT). Since Mar 24, 2008, Ted has reported 5 open-market purchases worth $2.3M and 5 sales worth $16.7M on SEC Form 4. There have been no open-market trades in the last 12 months.

Their filings also include grants and awards (80 filings), shares withheld for taxes (26 filings), option exercises (26 filings), shares returned to the company (8 filings). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every GBT insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.